Literature DB >> 25436128

Intestinal metaplasia and anastomotic recurrence of gastric carcinoma.

Elroy Patrick Weledji1, George Enow Orock1, Marcelin Ngowe Ngowe1.   

Abstract

Intestinal metaplasia (IM) of the stomach has been shown to increase the relative risk of gastric cancer. Endoscopic surveillance has been proposed and advocated for populations at risk. Those patients who had undergone surgery for gastric malignancy exhibited precancerous lesions such as atrophic gastritis and IM, and the possibility of anastomotic recurrence is higher than for the patients who had undergone benign gastric surgery. At present, there are no other recognized good markers of gastric dysplasia or cancer. We reviewed the literature on IM of the stomach to ascertain whether residual premalignant (type III) IM may predispose to anastomotic recurrence of gastric cancer.

Entities:  

Keywords:  Intestinal metaplasia (IM); anastomosis; gastric carcinoma; recurrence

Year:  2014        PMID： 25436128      PMCID： PMC4226823          DOI： 10.3978/j.issn.2078-6891.2014.048

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


  37 in total

1.  Mucins as key molecules for the classification of intestinal metaplasia of the stomach.

Authors:  Elisabete Silva; Ana Teixeira; Leonor David; Fátima Carneiro; Celso A Reis; Joana Sobrinho-Simões; Jacinta Serpa; Enno Veerman; Jan Bolscher; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2001-12-15       Impact factor: 4.064

Review 2.  Epidemiologic trends in esophageal and gastric cancer in the United States.

Authors:  Linda Morris Brown; Susan S Devesa
Journal:  Surg Oncol Clin N Am       Date:  2002-04       Impact factor: 3.495

3.  Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences.

Authors:  Xiaocheng Wu; Vivien W Chen; Patricia A Andrews; Bernardo Ruiz; Pelayo Correa
Journal:  Cancer Causes Control       Date:  2007-04-04       Impact factor: 2.506

Review 4.  Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies.

Authors:  Annemarie C de Vries; Ernst J Kuipers
Journal:  Helicobacter       Date:  2007-11       Impact factor: 5.753

5.  The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma.

Authors:  J R Jass; M I Filipe
Journal:  Histochem J       Date:  1981-11

6.  Mucosal changes in the gastric remnant: long-term effects of bile reflux diversion and Helicobacter pylori infection.

Authors:  Kristina Ahsberg Johannesson; Eric Hammar; Christer Staël von Holstein
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-01       Impact factor: 2.566

7.  Gastric intestinal metaplasia in ethnic groups in the southwestern United States.

Authors:  M B Fennerty; J C Emerson; R E Sampliner; D L McGee; L J Hixson; H S Garewal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1992 May-Jun       Impact factor: 4.254

8.  Incidence, diagnosis and significance of multiple gastric cancer.

Authors:  Y Kodera; Y Yamamura; A Torii; K Uesaka; T Hirai; K Yasui; T Morimoto; T Kato; T Kito
Journal:  Br J Surg       Date:  1995-11       Impact factor: 6.939

9.  Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives.

Authors:  David K Espey; Xiao-Cheng Wu; Judith Swan; Charles Wiggins; Melissa A Jim; Elizabeth Ward; Phyllis A Wingo; Holly L Howe; Lynn A G Ries; Barry A Miller; Ahmedin Jemal; Faruque Ahmed; Nathaniel Cobb; Judith S Kaur; Brenda K Edwards
Journal:  Cancer       Date:  2007-11-15       Impact factor: 6.860

10.  Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica.

Authors:  Sergio A Con; Reinaldo Con-Wong; Gil R Con-Chin; Vicky G Con-Chin; Hiroaki Takeuchi; Ana L Valerín; Guillermo Echandi; Fernando Mena; Fernando Brenes; Nobufumi Yasuda; Keijiro Araki; Tetsuro Sugiura
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-12       Impact factor: 4.254
View more
  1 in total

1.  hTERT promotes gastric intestinal metaplasia by upregulating CDX2 via NF-κB signaling pathway.

Authors:  Bai-Jun Chen; Shuo Zeng; Rui Xie; Chang-Jiang Hu; Su-Ming Wang; Yu-Yun Wu; Yu-Feng Xiao; Shi-Ming Yang
Journal:  Oncotarget       Date:  2017-04-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.